Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p
- PMID: 16939810
- DOI: 10.1016/j.exphem.2006.05.005
Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p
Abstract
Objective: Adenoviral vectors (Ad) were widely used in gene therapy and study of gene function, but the commonly used serotype 5 adenovirus-based vectors (Ad5) could poorly transduce hematopoietic cells because of low expression of viral receptors on these cells. To overcome this limitation, we developed a retargeting adenovector with a chimeric fiber of Ad5 and Ad11p (Ad5F11p) and evaluated its gene transfer ability in hematopoietic cells.
Materials and methods: An Ad11p fiber pseudotyped Ad5 vector was generated by modifying the fiber gene of pAdEasy-1 backbone plasmid. Ad5F11p-GFP encoding enhanced green fluorescence protein (GFP) gene was transferred into human leukemic cell lines, primary leukemic cells, and CD34(+) hematopoietic cells. The gene transduction efficiency was determined by fluorescence-activated cell sorting assay.
Results: More than 90% of U937 or K562 cells could be infected by Ad5F11p-GFP at a moderate multiplicity of infection (MOI). Ad5F11p-GFP is also significantly more effective than control Ad5-GFP in infection of primary myeloid leukemic cells. At 200 MOI, GFP-positive percentages of Ad5F11p-GFP transduced myeloid leukemic cells range from 10.58% to 92.63% with a median of 28.65%. Ad5F11p-GFP could transduce about 50% human hematopoietic stem/progenitor (CD34(+)) cells, while Ad5-GFP could transduce <15% at 200 MOI. CD46 was reported to be the receptor of Ad11p. Our data suggest that CD46 participates in the process of Ad5F11p-GFP infection but is not the unique molecule determining its gene transfer efficiency of host cells.
Conclusion: We established a retargeting adenovector system, which could infect hematopoietic cells effectively and would benefit research work on Ad tropism.
Similar articles
-
Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.Gene Ther. 2003 Jun;10(12):1041-8. doi: 10.1038/sj.gt.3301959. Gene Ther. 2003. PMID: 12776162
-
Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.Gene Ther. 2005 Oct;12(19):1424-33. doi: 10.1038/sj.gt.3302562. Gene Ther. 2005. PMID: 15944730
-
Efficient infection of primitive hematopoietic stem cells by modified adenovirus.Gene Ther. 2001 Jun;8(12):930-7. doi: 10.1038/sj.gt.3301488. Gene Ther. 2001. PMID: 11426333
-
Adenovirus vector-mediated gene transfer into stem cells.Mol Pharm. 2006 Mar-Apr;3(2):95-103. doi: 10.1021/mp0500925. Mol Pharm. 2006. PMID: 16579638 Review.
-
Adenoviral vectors for transient gene expression in human primitive hematopoietic cells: applications and prospects.Exp Hematol. 2007 Mar;35(3):343-9. doi: 10.1016/j.exphem.2006.11.004. Exp Hematol. 2007. PMID: 17309814 Review.
Cited by
-
Efficient clinical scale gene modification via zinc finger nuclease-targeted disruption of the HIV co-receptor CCR5.Hum Gene Ther. 2013 Mar;24(3):245-58. doi: 10.1089/hum.2012.172. Epub 2013 Mar 6. Hum Gene Ther. 2013. PMID: 23360514 Free PMC article.
-
In Vivo Hematopoietic Stem Cell Transduction.Hematol Oncol Clin North Am. 2017 Oct;31(5):771-785. doi: 10.1016/j.hoc.2017.06.001. Hematol Oncol Clin North Am. 2017. PMID: 28895846 Free PMC article. Review.
-
Establishment of a Parvovirus B19 NS1-Expressing Recombinant Adenoviral Vector for Killing Megakaryocytic Leukemia Cells.Viruses. 2019 Sep 4;11(9):820. doi: 10.3390/v11090820. Viruses. 2019. PMID: 31487941 Free PMC article.
-
Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.Mol Cell Biochem. 2011 Jul;353(1-2):93-9. doi: 10.1007/s11010-011-0778-5. Epub 2011 Mar 25. Mol Cell Biochem. 2011. PMID: 21437625
-
A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression.Virol J. 2017 Aug 8;14(1):149. doi: 10.1186/s12985-017-0818-1. Virol J. 2017. PMID: 28789701 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical